REGN Regeneron Pharmaceuticals, Inc.

$603.05
C+
Dividend Yield0.60%
Annual Dividend$3.64
Payout Ratio
Safe8.90%
Consecutive Years0 yrs
Frequencyquarterly
Next Ex-Date
N/A
View full dividend history →

Dividend Grades

vs Healthcare sector
C+
Overall
D+
Yield
N/AGrowth
A+
Safety
D
Consistency
B-
Performance
MetricREGNSector Median
Dividend Yield0.60%1.51%
Dividend Growth (5Y)6.62%
Payout Ratio8.9%29.1%
Consecutive Years Paid216
1Y Total Return+20.3%5.5%

Grades compare this stock to Healthcare sector peers using percentile ranks. A+ = top 10%, F = bottom 10%. See methodology →

1-Year Growth

N/A

3-Year Growth

N/A

5-Year Growth

N/A

10-Year Growth

N/A

Key Dividend Dates

Next Ex-Date

N/A

Next Payment

N/A

Last Ex-Date

May 20, 2026

Last Payment

Jun 4, 2026

Dividend History

Ex-DateAmountChange
May 20, 2026$0.94000.00%
Feb 20, 2026$0.9400+6.82%
Nov 20, 2025$0.88000.00%
Aug 18, 2025$0.88000.00%
May 20, 2025$0.88000.00%
Feb 20, 2025$0.8800N/A

Payout Ratio (Earnings)

8.9%

Safe

FCF Payout Ratio

9.4%

Safe

Financial Snapshot

PeriodEPSFCF
Q1 2026$6.99$848.30M
Q1 2025$7.58$773.60M
Q2 2025$13.24$967.60M
Q3 2025$14.09$1.42B

Analyst Ratings (Last 90 Days)

Buy: 0Hold: 19Sell: 0

Peer Comparison

SymbolCompanyYield
RPRXRoyalty Pharma plc1.73%
TECHBio-Techne Corporation0.55%
XOMAOXOMA Corporation8.23%
SVASinovac Biotech Ltd.3400.31%
XOMAPXOMA Royalty Corporation 8.625% Series A Cumulative Perpetual Preferred Stock2.12%
About this data

Dividend data sourced from Financial Modeling Prep. Prices updated daily after market close.

Payout ratio — trailing 12-month dividends paid / trailing 12-month net income.

Consecutive years — calendar years with a higher total annual dividend than the prior year.

Growth rates — annualized, comparing the most recent full year total to the total N years prior.

For informational purposes only. Not investment advice.

Data as of June 21, 2026. Source: Financial Modeling Prep. Prices and yields updated daily after market close.